Australia markets closed

Integra LifeSciences Holdings Corporation (IART)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
29.25+0.40 (+1.39%)
At close: 04:00PM EDT
28.80 -0.45 (-1.54%)
After hours: 04:03PM EDT

Integra LifeSciences Holdings Corporation

1100 Campus Road
Princeton, NJ 08540
United States
609 275 0500
https://www.integralife.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees3,946

Key executives

NameTitlePayExercisedYear born
Dr. Stuart M. Essig Ph.D.Executive Chairman152.5kN/A1962
Mr. Jan De WittePresident, CEO & Director888.67kN/A1964
Ms. Lea Daniels KnightExecutive VP & CFO673.15kN/A1972
Mr. Jeffrey A. MosebrookSenior VP of Finance & Principal Accounting Officer493.14kN/A1976
Mr. Eric Ian SchwartzExecutive VP, Chief Legal Officer & Secretary549.52kN/A1969
Mr. Robert T. Davis Jr.Executive VP & President of Tissue Technologies529.05k44.39k1959
Mr. Michael J. McBreenExecutive VP & President of Codman Specialty Surgical611.28kN/A1967
Mr. Stephen LeonardCorporate VP of Global Operations & Supply ChainN/AN/A1962
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Corporate governance

Integra LifeSciences Holdings Corporation’s ISS governance QualityScore as of 1 June 2024 is 1. The pillar scores are Audit: 1; Board: 4; Shareholder rights: 1; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.